Citadel Advisors’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,347,859
| Closed | -$7.4M | – | 7127 |
|
|
2025
Q1 | $7.4M | Buy |
1,347,859
+514,531
| +62% | +$2.82M | ﹤0.01% | 1468 |
|
|
2024
Q4 | $2.82M | Buy |
+833,328
| New | +$2.82M | ﹤0.01% | 2260 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6819 |
|
|
2024
Q2 | – | Sell |
-95,348
| Closed | -$211K | – | 6920 |
|
|
2024
Q1 | $211K | Sell |
95,348
-305,229
| -76% | -$675K | ﹤0.01% | 4735 |
|
|
2023
Q4 | $941K | Buy |
400,577
+371,383
| +1,272% | +$873K | ﹤0.01% | 3091 |
|
|
2023
Q3 | $54.3K | Buy |
+29,194
| New | +$54.3K | ﹤0.01% | 5056 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6567 |
|
|
2023
Q1 | – | Sell |
-21,240
| Closed | -$28.2K | – | 6639 |
|
|
2022
Q4 | $28.2K | Sell |
21,240
-14,910
| -41% | -$19.8K | ﹤0.01% | 5461 |
|
|
2022
Q3 | $57K | Sell |
36,150
-52,173
| -59% | -$82.3K | ﹤0.01% | 5278 |
|
|
2022
Q2 | $136K | Sell |
88,323
-54,891
| -38% | -$84.5K | ﹤0.01% | 5157 |
|
|
2022
Q1 | $366K | Buy |
143,214
+28,867
| +25% | +$73.8K | ﹤0.01% | 4756 |
|
|
2021
Q4 | $335K | Buy |
114,347
+38,513
| +51% | +$113K | ﹤0.01% | 5019 |
|
|
2021
Q3 | $186K | Buy |
75,834
+1,592
| +2% | +$3.91K | ﹤0.01% | 5475 |
|
|
2021
Q2 | $302K | Sell |
74,242
-33,820
| -31% | -$138K | ﹤0.01% | 5207 |
|
|
2021
Q1 | $487K | Buy |
108,062
+49,265
| +84% | +$222K | ﹤0.01% | 4598 |
|
|
2020
Q4 | $289K | Buy |
58,797
+35,391
| +151% | +$174K | ﹤0.01% | 4267 |
|
|
2020
Q3 | $139K | Sell |
23,406
-8,982
| -28% | -$53.3K | ﹤0.01% | 4178 |
|
|
2020
Q2 | $86K | Buy |
+32,388
| New | +$86K | ﹤0.01% | 4272 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 5384 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 5194 |
|
|
2019
Q2 | – | Sell |
-29,941
| Closed | -$301K | – | 5167 |
|
|
2019
Q1 | $301K | Buy |
+29,941
| New | +$301K | ﹤0.01% | 3727 |
|
|
2018
Q3 | – | Sell |
-11,290
| Closed | -$214K | – | 4778 |
|
|
2018
Q2 | $214K | Buy |
+11,290
| New | +$214K | ﹤0.01% | 3646 |
|